- The FDA’s Advisory Committeerecommendedthe approval of Moderna’s COVID-19 vaccine for children under 5 years old. The FDA alsofoundthat Pfizer COVID vaccine appears to be safe and effective for children under 5. Similar to the Moderna vaccine, authorization could be imminent, which would lead to vaccine distribution within the same week.
- A medical record studyshowsthat COVID-19 infection during pregnancy increases the risk of developmental delays in newborns.
- An observational studysuggestsModerna’s COVID-19 vaccine has a slightly better safety profile compared to the Pfizer vaccine and provides evidence supporting the safety of mRNA COVID-19 vaccines.
- A newly developed blood test can helpmeasureindividuals’ immune strength to COVID-19, helping doctors better understand at-risk patients.
- The CDC updated its website and guidelines including:
White House and Federal Agencies
- The Biden Administration plans to unveil anew response planin preparation for future pandemics.
Economy, Vaccines, Testing and Treatment
- The FDA’s Advisory Committeerecommendedthe approval of Moderna’s COVID-19 vaccine for children under 5 years old. The FDA alsofoundthat Pfizer COVID vaccine appears to be safe and effective for children under 5. Similar to the Moderna vaccine, authorization could be imminent, which would lead to vaccine distribution within the same week.
- A medical record studyshowsthat COVID-19 infection during pregnancy increases the risk of developmental delays in newborns.
- The U.S. seven-day average of new COVID-19 cases hasincreasedthis week, after a decrease in new case totals last week for the first time since late March.
- 研究finds rebounding COVID symptoms are rare after Paxlovid treatment. Of the 483 patientsparticipatingin the study, only 4 experienced symptoms rebounding after completion of the Paxlovid medication.
- A new studyshowsthat low-vaccinated areas have a greater risk of death from the Omicron variant. The research revealed that while communities with high vaccination rates (>60%) reported higher case incidence, communities with low vaccination rates (<60%) experienced over twice as high of a case-fatality ratio during the recent Omicron wave.
- An observational studysuggestsModerna’s COVID-19 vaccine has a slightly better safety profile compared to the Pfizer vaccine and provides evidence supporting the safety of mRNA COVID-19 vaccines.
- Astudyshows that the risk of COVID-related multi-system inflammatory syndrome in children was over 80% less during the Omicron wave compared to the Delta variant wave, regardless of vaccination status.
- An Israeli study points to a possibleconnectionbetween COVID-19 and acute liver failure in children. The research addresses the more than 700 cases of acute hepatitis in younger children after contracting COVID-19 across 34 countries.
- A newly developed blood test can helpmeasureindividuals’ immune strength to COVID-19, helping doctors better understand at-risk patients.
Centers for Disease Control and Prevention (CDC) Updates
The CDC published the following reports and website updates:
- Cases in the U.S.
- Overall U.S. COVID-19 Vaccine Distribution and Administration Update as of Wed, 15 Jun 2022 06:00:00 EST
- Notes from the Field: Diagnosis and Investigation of Pneumonic Plague During a Respiratory Disease Pandemic — Wyoming, 2021
- Notes from the Field: COVID-19–Associated Mortality Risk Among Long-Term Care Facility Residents and Community-Dwelling Adults Aged ≥65 Years — Illinois, December 2020 and January 2022
- COVID-19 Cases and Hospitalizations Among Medicare Beneficiaries With and Without Disabilities — United States, January 1, 2020–November 20, 2021
- CDC Rescinds Order Requiring Negative Pre-Departure COVID-19 Test Prior to Flight to the U.S.
- Interim Clinical Considerations for COVID-19 Treatment in Outpatients
- Underlying Medical Conditions Associated with High Risk for Severe COVID-19: Information for Healthcare Providers
- Overview of Testing for SARS-CoV-2 (COVID-19)
- Coronavirus Disease 2019 (COVID-19)
- COVID-19 Travel Recommendations by Country
- Non-U.S. citizen, Non-U.S. immigrants: Air Travel to the United States
- Requirement for Proof of COVID-19 Vaccination for Air Passengers
- Selected Adverse Events Reported after COVID-19 Vaccination
- COVID-19 Vaccines While Pregnant or Breastfeeding
- Air Travel Toolkit for Airline Partners
- Travel: Frequently Asked Questions and Answers
- Travel
- Information About Johnson & Johnson’s Janssen COVID-19 Vaccine
- Information about the Moderna COVID-19 Vaccine
- Information about the Pfizer-BioNTech COVID-19 Vaccine
- Southern Border Toolkit for Partners
- COVID Data Tracker Weekly Review
- Correctional and Detention Facilities
- Communication Resources for Travelers
- COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021
- Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022
- Archive of COVID-19 Vaccination Data Updates
- Steps for Determining Close Contact and Quarantine in K–12 Schools
- Responding to COVID-19 Cases in K-12 Schools: Resources for School Administrators
- Health Equity
